Coya Therapeutics, Inc. (COYA) vs Immunic, Inc. (IMUX)
Coya Therapeutics, Inc. and Immunic, Inc. are both Biotechnology companies. Coya Therapeutics, Inc. and Immunic, Inc. are of similar size ($127.2M and $121.5M). Immunic, Inc. has the higher net margin (0.00% vs −270.2%) and the higher return on invested capital (0.00% vs −15,230.9%). Across the 13 metrics below, Coya Therapeutics, Inc. leads on 7 and Immunic, Inc. on 6.
Valuation
Profitability
| Metric | COYA | IMUX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | (288.70%) | 0.00% | 0.00% |
| Net margin | (270.22%) | 0.00% | 0.00% |
| Free cash flow margin | (221.64%) | 0.00% | 0.00% |
| Return on equity | (60.54%) | (138.17%) | (57.72%) |
| Return on assets | (53.66%) | (101.15%) | (49.22%) |
| Return on invested capital | (15,230.92%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack